Atherosclerosis and coronary artery disease are the major cause of mortality in Western societies. Atheroma development is a chronic inflammatory process resulting from the interaction between modified lipoproteins, circulating leukocytes, and elements of the arterial wall, including endothelial cells, monocyte-derived macrophages, T cells, and vascular smooth muscle cells (VSMCs) (1) (2) (3) (4) . The disease in humans and experimental animals is characterized by excessive cell proliferation and apoptosis within the atheroma, 2 processes that affect mainly macrophages and VSMCs (5) (6) (7) (8) (9) .
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The tumor suppressors p15 INK4b , p16 INK4a , and ARF (p14 ARF in humans, p19 ARF in mice) constitute one of the main antioncogenic defenses of mammalian organisms (10, 11) . The CDKN2A gene encodes the nonhomologous proteins p16 INK4a and ARF, and the adjacent CDKN2B gene encodes p15 INK4b . p16
INK4a and p15 INK4b cause growth arrest through the inhibition of CDK4 and CDK6 activity and the ensuing accumulation of the hypophosphorylated form of the retinoblastoma protein (12, 13) . ARF appears to play a more relevant role as a proapoptotic factor via inhibition of MDM2, a ubiquitin ligase that destabilizes the tumor suppressor p53 (10, 11) . Furthermore, age-dependent expression of p16 INK4a and ARF may limit the regenerative potential of stem cell pools in certain tissues (14 -17) .
By analyzing a small cohort that included 316 patients and 434 controls, Rodriguez et al. (18) reported lack of association between the risk of suffering myocardial infarction and the single nucleotide polymorphisms (SNPs) rs3731238, rs3814960, and rs3731249 located in the CDKN2A gene. However, recent independent genome-wide association studies that included thousands of controls and patients have identified a number of SNPs located in a region of chromosome 9p21 very close to the CDKN2A gene that are linked to high risk of atherosclerosis and associated cardiovascular disease, including coronary artery disease, myocardial infarction, and ischemic stroke (19 -25) . Interestingly, Liu et al. (26) recently reported reduced expression of the CDKN2A transcripts p16 INK4a , p14 ARF , and the noncoding RNA named ANRIL (antisense noncoding RNA in the INK4 locus) in purified peripheral blood T cells of individuals carrying in homozygosis the atherosclerosis risk G allele of rs10757278. These studies suggest a molecular mechanism by which diminished expression of CDKN2A transcripts associated to genetic variants in this locus increases the risk of atherosclerosis. However, a causal link between reduced CDKN2A expression and atherosclerosis has not been established. Here, we investigated the consequences of inactivating p19 ARF on atheroma development in the widely used apolipoprotein E-null (apoE
) mouse model of atherosclerosis.
Methods
Mice, diets, and metabolic measurements. Care of animals was in accordance with institutional guidelines and regulations. Mice deficient for p19 ARF (p19 Ϫ/Ϫ ) (27) were backcrossed for more than 8 generations in a C57BL/6J background and then were crossed with apoE Ϫ/Ϫ mice (C57BL/6J, Charles River, Wilmington, Massachusetts) to generate doubly deficient apoE Ϫ/Ϫ p19 Ϫ/Ϫ mice. Information for genotyping of mice is provided in the Online Appendix. After weaning, mice were maintained on a low-fat standard diet (2.8% fat; Panlab, Barcelona, Spain). At 2 months of age, male apoE Ϫ/Ϫ and apoE
littermates were placed for different periods of time on an atherogenic diet (10.8% total fat, 0.75% cholesterol without sodium cholate, S4892-E010, Ssniff, Soest, Germany). Plasma lipid levels in mice fasted overnight were measured using enzymatic procedures (WAKO, St. Louis, Missouri). High-density lipoprotein cholesterol (HDL-C) was determined after precipitation of the apolipoprotein B-containing lipoproteins with dextran sulphate/MgCl 2 (Sigma, St. Louis, Missouri) as previously described (28) . Quantification of atherosclerosis burden. Fat-fed mice were sacrificed and the aorta was removed after in situ perfusion with PBS followed by 4% paraformaldehyde/PBS. Fixation was continued overnight. An operator who was blinded to genotype quantified the extent of atherosclerosis by computer-assisted morphometric analysis (SigmaScan Pro5, Aspire Software International, Ashburn, Virginia) of both whole-mounted aorta stained with Oil Red O (0.2% Oil Red O in 80% MeOH) (Sigma) and hematoxylin/eosin-stained crosssections of paraffin-embedded aortic root and ascending aorta as previously described (29) . Immunohistochemical analysis of atherosclerotic plaques. Immunohistopathological examination of atheromas performed by a researcher blinded to genotype included the quantification of the content of macrophages, VSMCs, and collagen (Masson's trichrome stain). VSMCs were identified with mouse anti-smooth muscle (SM) ␣-actin monoclonal alkaline phosphatase-conjugated antibody (1/20 dilution, clone 1A4) and Fast Red substrate (both from Sigma). Macrophages were detected with a rat anti-Mac3 monoclonal antibody (1/200 dilution, clone M3/84, sc-19991, Santa Cruz Biotechnology, Santa Cruz, California), followed by biotin-conjugated goat anti-rat secondary antibody (1/300 dilution, sc-2041, Santa Cruz Biotechnology), streptavidin-HRP (Ref. TS-060-HR, Lab Vision Corporation, Fremont, California), and DAB substrate (BUF021A, AbD Serotec). Specimens were counterstained with hematoxylin.
Cell proliferation in atheromatous lesions from the aortic valves and ascending aorta was estimated by immunostaining with a pre-diluted rabbit anti-Ki67 monoclonal antibody (Clone SP6, MD, Vector Laboratories, Burlingame, California), followed by incubation with a biotinylated anti-rabbit secondary antibody (1/300 dilution, Ref. R0919, Vector Laboratories), streptavidin-HRP, and DAB substrate.
Apoptosis in the aortic valve region was determined using the TUNEL method as recommended by the manufacturer (ApopTag Peroxidase In Situ Apoptosis Detection Kit, Ref. S7100, Millipore Ibérica, Madrid, Spain). Immunocomplexes were detected with DAB substrate and counterstained with hematoxylin.
For double TUNEL-Mac3 and TUNEL-SM ␣-actin staining, TUNEL-stained slides were incubated with the anti-Mac3 or anti-SM ␣-actin antibodies, respectively (see the previous text). The TUNEL-Mac3-stained specimens were incubated with biotin-conjugated goat anti-rat secondary antibody and streptavidin-alkaline phosphatase ( (29) . VSMC cultures were prepared from thoracic aorta harvested from 3-to 5-month-old animals after 2 digestions in HBSS/Fungizone medium as previously described (29) . Briefly, the aorta was first digested with type II collagenase (175 U/ml, Worthington Biochemical Corp., Lakewood, New Jersey) to remove the adventitia, and cell suspensions were obtained after a second digestion with type II collagenase (175 mg/ml) (Worthington) and type I Elastase (0.5 mg/ml) (Sigma). Cultures were maintained at 37°C in a humidified 5% CO 2 atmosphere. VSMCs were cultured in 20% FBS/DMEM/Fungizone and used until passage 10. The identity of the cells as VSMCs was confirmed by immunohistochemistry using anti-SM ␣-actin antibody (see the previous text). In vitro cell proliferation. For proliferation studies, asynchronously growing cultures of BMDMs were plated on glass coverslips and incubated with 50 M bromodeoxyuridine (BrdU) for 18 h. Cells were fixed for 30 min with 4% paraformaldehyde/PBS, permeabilized with 0.5% Triton X-100/2 M HCl, washed extensively with sodium borate buffer (pH 8.5), and incubated with a mouse monoclonal anti-BrdU antibody (1 h, room temperature, 1/200, clone MoBu-1, 11-286-c100, Exbio, Vestec, Czech Republic) followed by an Alexa Fluor 488 -conjugated goat antimouse secondary antibody (1 h, room temperature, 1/500, A11029, Invitrogen, Carlsbad, California). Cell nuclei were stained with Hoechst (1/500, 15 min, Sigma) for total cell count, and coverslips were mounted with slow-fade gold antifade reagent (S36936, Invitrogen) and analyzed by fluorescent microscopy. For VSMC FACS-based cell-cycle analysis, cells were synchronized in G0/G1 by 72-h serumdeprivation (DMEM-0.1% FBS) and then restimulated with DMEM-20% FBS for different times. Cells were trypsinized, washed with PBS, collected by centrifugation (5 min, 600g), fixed with 80% ethanol (1 h, Ϫ20°C), and labeled with propidium iodide (50 g/ml, 30 min at room temperature, containing 0.25 mg/ml RNase A). Cells were analyzed using a BD FACSCanto Flow cytometer (BD Biosciences) and DNA histograms were fitted into cellcycle distributions using the ModFit 3.0 software (Verity Software House, Topsham, Maine). In vitro apoptosis. Cells were either irradiated with ultraviolet (UV) light (BMDM: 80 J/m 2 , VSMC: 120 J/m 2 ) and cultured an additional 24 h (BMDM) or 48 h (VSMC), incubated with free-cholesterol at 100 g/ml (BMDM: 24 h, VSMC: 48 h), or incubated with the nitric oxide donor S-nitrosoglutathione (GSNO) (2 mM, Sigma) (BMDM: 24 h, VSMC: 48 h). For apoptosis analysis by flow cytometry, control and treated cells were collected by trypsinization at 37°C, rinsed with PBS, collected at low speed (700g, 5 min), and fixed for propidium iodide staining as described earlier or for cleaved caspase-3 staining as follows. Cells were fixed 10 min at 37°C with 2% to 4% paraformaldehyde/PBS, permeabilized with prechilled 90% methanol (30 min on ice), and stained with a rabbit polyclonal anti-cleaved caspase 3 (Asp175) antibody (1/200, Cell Signaling Technology, Beverly, Massachusetts), followed by Alexa Fluor 488-conjugated goat anti-rabbit IgG secondary antibody (F[ab=]2 fragment, 1 h at room temperature, 1/500, A-11070, Invitrogen). Apoptotic cells were identified as the sub-G0 peak subpopulation after propidium iodide staining or as cleaved caspase-3 (Asp175)-positive cells. Statistical analysis. Data are presented as mean Ϯ SEM. Differences among groups were evaluated by the Student t test, 2-way ANOVA with Fisher post hoc test (Statview, SAS institute, Cary, North Carolina) or nonparametric Mann-Whitney U test (GraphPad Prism Software, La Jolla, California). Outliers identified by Grubb's test were not considered for quantification.
Results

Genetic disruption of p19
ARF accelerates atherosclerosis in apoE ؊/؊ mice. To assess the role of p19 ARF on atherosclerosis, 2-month-old apoE Ϫ/Ϫ mice and apoE
siblings were fed a high-fat cholesterol-rich diet for 9 weeks. As shown in Figure 1A , body weight increased in both groups of mice during the period of fat feeding, reaching statistically significant differences in apoE Ϫ/Ϫ mice at 4 and 9 weeks versus 0 and 1 week, and in apoE
Ϫ/Ϫ mice at 4 weeks versus 0 week and at 9 weeks versus 0, 1, and 4 weeks (see p values in Fig. 1A ). No differences were observed between apoE Ϫ/Ϫ and apoE Ϫ/Ϫ p19 Ϫ/Ϫ mice at any time point analyzed. Likewise, circulating levels of total cholesterol and triacylglycerides increased significantly in both groups of fat-fed mice compared with their pre-diet values (Fig. 1B) , but no differences were seen when comparing apoE Ϫ/Ϫ and apoE
Thus, body weight and circulating lipids in control and fat-fed apoEnull mice remained unaffected by genetic disruption of p19 ARF . We next quantified atherosclerosis burden by planimetric analysis of whole-mounted oil Red-O-stained aortic arch and thoracic aorta and by analyzing crosssections through the aortic root and ascending aorta. Compared with apoE Ϫ/Ϫ counterparts, apoE Ϫ/Ϫ p19 Ϫ/Ϫ mice exhibited a significant increase in atheroma size in the aortic arch (1.5-fold, p Ͻ 0.012) (Fig. 1C ) and aortic root (1.7-fold increase, p Ͻ 0.018) (Fig. 1D ), 2 highly atherogenic vascular beds in this animal model. In contrast, p19 ARF inactivation did not affect plaque size in the less atherogenic thoracic aorta (Fig. 1C ) and ascending aorta (Fig. 1D) .
We also examined the consequences of inactivating p19 ARF on plaque composition. Analysis of the aortic root and ascending aorta revealed no differences in lesional (neointimal) content of Mac3-immunoreactive macrophages, SM ␣-actin-immunoreactive VSMCs and collagen between apoE Ϫ/Ϫ p19 Ϫ/Ϫ and apoE Ϫ/Ϫ mice (Fig. 2) . Likewise, lesion cellularity in the aortic root was similar in both groups (apoE Ϫ/Ϫ : 6.21 Ϯ 1.02 cells/mm 2 , n ϭ 11; apoE Ϫ/Ϫ p19 Ϫ/Ϫ : 6.07 Ϯ 1.13 cells/mm 2 , n ϭ 10).
Effects of p19
ARF inactivation on cell proliferation and apoptosis in atherosclerotic lesions and macrophage and VSMC cultures. We next sought to investigate the mechanisms underlying the atheroprotective action of p19 ARF . Since a key event in lesion development is the uptake of modified low-density lipoproteins (LDLs) by macrophages (1), we analyzed this process in cultures of peritoneal macrophages obtained from apoE Ϫ/Ϫ and apoE Ϫ/Ϫ p19 Ϫ/Ϫ mice, which exhibited similar uptake of acetylated LDLs (data not shown). We also examined the effect of disrupting p19 ARF on proliferation and apoptosis, 2 important cellular processes during atherosclerosis (5) (6) (7) (8) (9) 30 (Fig. 3A) and flow cytometric analysis (not shown). In contrast, apoE Ϫ/Ϫ p19 Ϫ/Ϫ VSMCs entered earlier into the S and G2/M phases of the cell cycle compared with apoE Ϫ/Ϫ controls, as determined by flow cytometric analysis of starvation-synchronized cultures that were restimulated with serum (Fig. 3B) . These studies demonstrated a significantly higher percentage of cells in G1/G0 in apoE Ϫ/Ϫ versus apoE (Fig. 3C) , as estimated by the neointimal content of Ki67-positive cells. Likewise, : 52.9 Ϯ 5.6% Ki67-positive cells, n ϭ 11; apoE
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: 46.9 Ϯ 4.8% Ki67-positive cells, n ϭ 10, p Ͼ 0.05). Neointimal cell proliferation was also undistinguishable in apoE Ϫ/Ϫ and apoE Ϫ/Ϫ p19 Ϫ/Ϫ mice fed the atherogenic diet for 4 weeks, which exhibited incipient lesions (Online Fig. S1 ). Interestingly, the mRNA level of the cytostatic gene product p16
INK4a was markedly increased in the aortic arch of apoE Ϫ/Ϫ p19 Ϫ/Ϫ mice fed the atherogenic diet for 4 weeks (ϳ17-fold increase vs. apoE Ϫ/Ϫ , p Ͻ 0.05) and 9 weeks (ϳ23-fold increase vs. apoE Ϫ/Ϫ , p Ͻ 0.0005) (Online Fig.  S2A ). This compensatory mechanism does not occur in cultured VSMCs, since no statistically significant differences in p16
INK4a expression were detected when comparing Gonzá lez-Navarro et al. May 18, 2010 May 18, :2258 p19 ARF Deficiency Aggravates Atherosclerosis cells of both genotypes (Online Fig. S2B ). We also observed that expression of p15 INK4b in both aortic tissue and cultured VSMCs is unaffected by disrupting p19 ARF (Online Fig. S2 ). Thus, p19 ARF ablation increases significantly the proliferative capacity of cultured VSMCs in vitro but does not affect neointimal cell proliferation at different lesional stages, possibly due to a compensatory upregulation of p16
INK4a in aortic tissue. To assess the role of p19 ARF in plaque's apoptosis, aortic root cross-sections were examined using the terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) method. We found a significant reduction in the percentage of TUNEL-positive cells in atheromas from apoE Ϫ/Ϫ p19 Ϫ/Ϫ compared with apoE Ϫ/Ϫ mice, both when quantified as percentage TUNEL-positive cells and as absolute number of TUNEL-positive cells per square millimeter of lesion (Fig. 4A) . We also carried out double-staining experiments to identify apoptotic neointimal macrophages (TUNEL/Mac3) and VSMCs (TUNEL/SM ␣-actin). In both groups of mice, ϳ70% VSMCs compared with untreated controls (not shown). This lack of apoptotic response in free-cholesteroltreated VSMCs correlated with the absence of intracellular cholesterol vesicles, which were abundant in BMDMs exposed to this lipid (not shown).
Discussion
The major finding of the present study is that deficiency of the p19 ARF protein, one of the tumor suppressors encoded by the CDKN2A gene, accelerates atheroma development in the atherosclerosis-prone aortic arch (en face study) and aortic root (analyzed in tissue cross-sections) of hypercholesterolemic apoE-null mice (Fig. 1) . This phenotype is not observed in less atherogenic regions of the same mice (e.g., ascending and thoracic aorta), suggesting that p19 ARF is not involved in the initiation of atherosclerosis but regulates atheroma development in more advanced stages of the disease. Notably, apoptosis is reduced in apoE Ϫ/Ϫ p19 Ϫ/Ϫ compared with apoE Ϫ/Ϫ plaques (Fig. 4) , and p19 ARF inactivation attenuates apoptosis in primary cultures of macrophages and VSMCs exposed to different pro-apoptotic stimuli (Fig. 5) . Of note, recent genome-wide association studies in humans have reported an association between several SNPs in a region of chromosome 9p21 adjacent to the CDKN2A/CDKN2B loci and the risk of atherosclerotic diseases (19 -25) . Moreover, it has been shown that expression of transcripts encoded by these genes (e.g., p15
INK4b , p16
INK4a , ANRIL, and p14 ARF , the human homolog of murine p19 ARF ) is lower in purified peripheral blood T cells of individuals homozygous for the atherosclerosis risk G allele of one of these SNPs (rs10757278) (26) . Thus, our findings demonstrating a direct link between p19 ARF , plaque apoptosis, and atherosclerosis burden in apoE Ϫ/Ϫ mice suggest a molecular mechanism by which diminished expression of ARF associated to genetic variants in the CDKN2A gene may increase the risk of atherosclerosis by limiting plaque apoptosis.
Because p19 ARF expression has been shown to promote cellular senescence to avoid proliferation of aberrant, potentially hazardous cells in some pathophysiological settings (e.g., aging and cancer) (10,11), we evaluated aortic cell senescence in apoE Ϫ/Ϫ (n ϭ 10) and apoE Ϫ/Ϫ p19 Ϫ/Ϫ (n ϭ 9) mice fed the atherogenic diet for 9 weeks. In both groups of mice, we found essentially negligible senescenceassociated beta-galactosidase staining in cryosections through the aortic valves, with some scarce, faintly positive cells within the neighboring cardiac tissue (data not shown). Thus, reduced aortic cell senescence does not appear to contribute to increased atherosclerosis in apoE
mice. We also investigated the consequences of disrupting p19 ARF on the expression of the proto-oncogen Myc, since both proteins have been shown to directly interact, and p14 ARF down-regulates Myc-activated transcription (32) . Quantitative polymerase chain reaction (qPCR) analysis demonstrated increased c-myc expression in mouse aortic VSMCs lacking p19 ARF (Online Fig. S3A ), which, together with the lack of compensatory up-regulation of p16 INK4a (Online Fig. S2B ), might contribute to the higher proliferative capacity of cultured apoE Ϫ/Ϫ p19 Ϫ/Ϫ VSMCs (Fig. 3B) . Similarly, p19
ARF inactivation augmented significantly c-myc expression in the aortic arch of apoE Ϫ/Ϫ mice fed the atherogenic diet for 4 weeks (Online Fig. S3B ), but this response did not correlate with changes in cell proliferation within the atheroma (Online Fig. S1 ). Moreover, c-myc expression was similar in apoE Ϫ/Ϫ and apoE Ϫ/Ϫ p19 Ϫ/Ϫ mice fed an atherogenic diet for 9 weeks (Online Fig. S3B) . Thus, the effect of p19 ARF on c-myc expression in the aortic arch appears to depend on lesional stage (e.g., increased expression in small lesions at 4 weeks of fat diet and no effect in more advanced lesions after 9 weeks of diet). Hence, further research appears warranted to elucidate the complex functional connections between c-myc, p19 ARF , and proliferation at different stages of atherosclerosis.
Both cell proliferation and apoptosis are prevalent in atherosclerotic lesions (5) (6) (7) (8) . Therefore, changes in the balance between hyperplastic growth and apoptosis of neointimal cells are of major importance in atherosclerosis development. Indeed, atheroma progression is affected in mice with altered expression of several tumor suppressors that modulate cell proliferation and apoptosis. Unlike p21
Cip1
, whose genetic ablation unexpectedly protects from atherosclerosis in apoE-null mice (33, 34) , the absence of p53 (35) (36) (37) (38) , p27
Kip1 (39, 40) , and retinoblastoma (41) proteins aggravates atherosclerosis in different murine models (apoE-null, LDL receptor-null, and apoE*3-Leiden transgenic mice). Excessive proliferation of macrophages and VSMCs has been suggested as a mechanism contributing to the acceleration of atherosclerosis in mice lacking p27 Kip1 , retinoblastoma, and p53. We also found increased atherosclerosis burden in apoE-null mice lacking p19 ARF ; however, this phenotype did not appear to correlate with increased cell proliferation within the plaque, possibly due to a marked up-regulation in aortic tissue of the INK4 family growth suppressor p16
INK4a (Online Fig. S2A ). This compensatory mechanism does not appear to occur in cultured VSMCs since apoE Ϫ/Ϫ p19 Ϫ/Ϫ VSMCs exhibited increased proliferative capacity compared with apoE Ϫ/Ϫ controls, and no statistically significant differences in p16
INK4a expression were detected between cells of both genotypes (Online Fig. S2B ).
In agreement with the well-established proapoptotic function of p19 ARF , our in vivo studies reveal a 2-fold reduction in the content of apoptotic cells in apoE
Ϫ/Ϫ compared with apoE Ϫ/Ϫ plaques (Fig. 4A) . Notably, we find that the
